Kennedy R. Lees
University of Glasgow
467 Papers
3.9K Citations
Kennedy R. Lees is an academic researcher from University of Glasgow. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 86, co-authored 455 publications. Previous affiliations of Kennedy R. Lees include Ludwig Maximilian University of Munich & Cedars-Sinai Medical Center.
Chat about Author
Papers
Selection for delayed intravenous alteplase treatment based on a prognostic score
Rachael L. Fulton,Kennedy R. Lees,Erich Bluhmki,Gabriele Biegert,Gregory W. Albers,Stephen M. Davis,Geoffrey A. Donnan,James C. Grotta,Werner Hacke,Markku Kaste,Rüdiger von Kummer,Ashfaq Shuaib,Danilo Toni,Ecass, Atlantis, Ninds,Epithet Investigators +14 more
TL;DR: In this article, the authors proposed prognostic scoring methods to identify a strategy for patient selection for intravenous alteplase for ischemic stroke, and applied these methods to the pooled randomized controlled trial data for 4·5-6h.
9
Professional guideline versus product label selection for treatment with IV thrombolysis: An analysis from SITS registry.
Alan C. Cameron,James Bogie,Azmil H. Abdul-Rahim,Niaz Ahmed,Niaz Ahmed,Michael V. Mazya,Michael V. Mazya,Robert Mikulik,Werner Hacke,Kennedy R. Lees +9 more
- 01 Mar 2018
TL;DR: The potential benefit of universally selecting by ESO guidance is estimated, using onset-to-treatment time-specific numbers needed to treat for day 90 mRS 0–1, which translates into 1922 more patients with favourable three-month outcomes.
9
Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.
TL;DR: Intravenous ACE inhibitor therapy appears to have a role in the treatment of acute heart failure and early after myocardial infarction and Practical experience with intravenous administration with activation of renin is limited.